Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia
- 1 February 2002
- journal article
- case report
- Published by American Society of Hematology in Blood
- Vol. 99 (3) , 1092-1094
- https://doi.org/10.1182/blood.v99.3.1092
Abstract
Pure red cell aplasia (PRCA) is a rare complication in patients with chronic lymphocytic leukemia (CLL). It is characterized by reticulocytopenia and by an absence of red cell precursors in the bone marrow. Unlike autoimmune hemolytic anemia, which is characterized by an increased number of reticulocytes, positive Coombs test findings, and a high serum level of lactate dehydrogenase. Two patients with B-cell CLL are reported to have developed PRCA, one while on chemotherapy with fludarabine and one seeking treatment for de novo PRCA. Both responded dramatically to therapy with monoclonal antibody rituximab (Rituxan) in a short period of time and continued to be transfusion-independent. These are the first 2 reported patients for whom rituximab treatment for PRCA in CLL was successful, and this treatment deserves further investigation.Keywords
This publication has 10 references indexed in Scilit:
- Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemiaBlood, 2001
- Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximabBlood, 2000
- Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three casesJournal of Hepatology, 2000
- Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.Journal of Clinical Oncology, 1998
- Chronic cold agglutinin disease of the “idiopathic” type is a premalignant or low‐grade malignant lymphoproliferative diseaseAPMIS, 1997
- Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20Blood, 1994
- Pure Red-Cell Aplasia in Patients with Chronic Lymphocytic LeukemiaMedicine, 1986
- Hypoplastic anemia in B cell chronic lymphocytic leukemia: evolution of T cell-mediated suppression of erythropoiesis in early-stage and late- stage diseaseBlood, 1985
- Acquired pure red cell aplasia associated with chronic lymphocytic leukemiaCancer, 1983
- T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia.Journal of Clinical Investigation, 1982